October 02, 2020
American Renal Associates Holdings Inc. said Friday it would be sold to a private equity firm for $853 million, unveiling the agreement the same day investors were notified of a $5.78 million deal to end class claims that the dialysis provider issued misleading financial statements.
January 21, 2020
American Renal Associates Holdings Inc. has told a New Jersey federal judge that class claims over a string of allegedly misleading financial statements were improperly premised on understatements of its revenue that ultimately resulted in an additional windfall for investors.